Impact to Date
With over a million dollars raised since 2017, the TDP has supported a range of sarcoma related projects in partnership with The Kids Cancer Project and the Cooper Rice Brading Foundation.
-
16,930
items sold
-
$1,177,370
raised since 2017
-
8 Major Projects Supported
Including research projects, clinical trials, fellowships and patient support programs.
CAR T Cell Therapy Clinical Trial
Children’s Cancer Research Unit has been conducting a clinical research project for the translation of CAR T therapy for sarcoma. The research aims to focus on the clinical translation of laboratory tested, genetically immune CAR T cells into Phase 1 trials for paediatric sarcoma patients, with the hope of extending this previously successful CAR T Therapy technology to solid tumours, like sarcoma.
Funds raised across the 2021 and 2023 Tie Dye Festivals ($115,500) were matched by The Kids Cancer Project, to contribute $231,000 towards this research. Thanks to this awareness, this is now a funded supported clinical trial.
NK Cell Therapy Project, QLD
With the support of TKCP ($100,000) and CRBF ($50,000), the TDP has contributed $100,000 to the NK Cell Therapy Project clinical trial, which aims to evaluate the potential of NK cell antitumour activity in osteosarcoma treatment. The trial is being conducted out of the University of Queensland, with very promising results thus far.
Sarcoma Fellowship
The TDP has committed to the allocation of funds for a 2 year sarcoma research fellowship, contributing $100,000, generously matched by the Kids Cancer Project.
Sarcoma Workflow Project
Alongside funding from The Kids Cancer Project, the TDP is committing to contributing $100,000 to the Sarcoma Workflow Project, which aims to analyse drug responses to determine effective therapeutic options specific to individual tumours. This will accelerate the translation of precision medicine from bench-to-bedside for childhood sarcoma patients.
Jack Gibson Sarcoma Patient & Family Support Programne
CRBF is a sarcoma-focused charity that dedicates themselves to significantly improving treatment options, optimal patient pathways, and survival outcomes for young sarcoma patients. The TDP contributes funding for the Jack Gibson Sarcoma Patient & Family Support Programme, which aims to support patients and families in "off-menu" ways, such as providing memorable experiences.